Lumida
/TXG
⌘K
10X Genomics Inc

10X Genomics Inc

TXG
$68.59USD+3.33%+2.21 today

MARKET CAP

8.9B

P/E (TTM)

FWD P/E

DAY RANGE

$67 – $70

52W RANGE

$11
$70

AI Summary

Stalk
StalkMedium

TXG is in a Stage 2 uptrend confirmed by steeply rising EMAs and an active Parabola pattern signaling aggressive trend acceleration. However, price is extreme overbought and extended well above the 9/20/50 EMAs, making immediate entries unfavorable. Medium-term bias remains bullish, with the preferred approach being to wait for pullbacks into the rising EMAs (9/20) for structural support and favorable risk/reward. A failure to hold these EMAs on a retracement would threaten the bullish stance.

  • EPS consensus revisions climbed 15.2% last three months, showing strong analyst sentiment
  • Collaborated with Lausanne University Hospital to advance cancer diagnostics
  • Q2 revenue dropped 12.7% YoY to $151M, hinting stagnation
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income